Status:
UNKNOWN
Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community
Lead Sponsor:
Barau Dikko Teaching Hospital
Conditions:
Sickle Cell Disease
Stroke
Eligibility:
All Genders
2-16 years
Phase:
NA
Brief Summary
The overall goal of this feasibility study is to establish a standard of care stroke prevention program for children with sickle cell anemia in a community hospital by task shifting stroke detection a...
Detailed Description
The overall goal of this feasibility study is to establish a standard of care stroke prevention program for children with sickle cell anemia in a community hospital by task shifting stroke detection a...
Eligibility Criteria
Inclusion
- Children with diagnosis of SCA (HbSS or HbSβthal0)
- 2-16 years receiving care at both YDMH (community hospital) and BDTH (teaching hospital).
- No previous stroke
Exclusion
- Children with SCA younger than 2 years or older than 16
- Children with stroke
- 2\) Children already on Hydroxyurea
Key Trial Info
Start Date :
January 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT05434000
Start Date
January 6 2021
End Date
July 31 2025
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barau Dikko Teaching Hospital/Kaduna State University
Kaduna, Nigeria